Name | 5-[[3-(trifluoromethyl)phenyl]methylidene]-1,3-thiazolidine-2,4-dione |
---|---|
Synonyms |
2,4-Thiazolidinedione (5-[[3-(trifluoromethyl)phenyl]methylene]
HMS3244E20 HMS3244E19 (5Z)-5-[3-(Trifluoromethyl)benzylidene]-1,3-thiazolidine-2,4-dione 2,4-Thiazolidinedione, 5-[[3-(trifluoromethyl)phenyl]methylene]-, (5Z)- SMI-4a (Z)-SMI-4a |
Description | (Z)-SMI-4a is a selective ATP-competitive Pim-1 kinase inhibitor with an IC50 of 21 nM for Pim-1 compared to an IC50 of 100 nM for Pim-2 and with little or no activity against a panel of 50 other kinases tested.IC50 value: 21 nM (Pim1); 100 nM (Pim2) [1]Target: Pim-1in vitro: Incubation of pre-T-LBL cells with (Z)-SMI-4a induced G1 phase cell-cycle arrest secondary to a dose-dependent induction of p27(Kip1), apoptosis through the mitochondrial pathway, and inhibition of the mammalian target of rapamycin C1 (mTORC1) pathway based on decreases in phospho-p70 S6K and phospho-4E-BP1, 2 substrates of this enzyme. In addition, treatment of these cells with (Z)-SMI-4a was found to induce phosphorylation of extracellular signal-related kinase1/2 (ERK1/2), and the combination of (Z)-SMI-4a and a mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor was highly synergistic in killing pre-T-LBL cells [1]. Ectopic expression of phosphomimetic mutants of eIF4B conferred resistance to apoptosis by the Pim kinase inhibitor (Z)-SMI-4a in Abl-transformed cells [2].in vivo: In immunodeficient mice carrying subcutaneous pre-T-LBL tumors, treatment twice daily with (Z)-SMI-4a caused a significant delay in the tumor growth without any change in the weight, blood counts, or chemistries [1]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C11H6F3NO2S |
Molecular Weight | 273.231 |
Exact Mass | 273.007141 |
PSA | 74.96000 |
LogP | 2.30 |
Appearance | white to beige |
Index of Refraction | 1.602 |
Storage condition | Desiccate at +4°C |
Water Solubility | DMSO: >10mg/mL |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H317-H319 |
Precautionary Statements | P280-P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Phrases | 36-43 |
Safety Phrases | 26-36/37 |
RIDADR | NONH for all modes of transport |